Export

Lisinopril + hydrochlorothiazide
Essential medicine status
General description

INN
Lisinopril + hydrochlorothiazide
Medicine type
Chemical agent
EML status history
Application rejected in 2017 (TRS 1006) for Essential hypertension
Therapeutic equivalent for
Recommendations
Section
Antihypertensive medicines
  • Oral > Solid: 10 mg + 12.5 mg; 20 mg + 12.5 mg; 20 mg + 25 mg